Steffen Dickopf

Title: Steffen Dickopf: Innovator in Antibody Generation

Introduction

Steffen Dickopf is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biochemistry, particularly in the generation of multispecific antibodies. His innovative approach has the potential to advance therapeutic applications in medicine.

Latest Patents

Steffen Dickopf holds a patent for a method titled "Method for in vivo generation of multispecific antibodies from monospecific antibodies." This patent describes a groundbreaking technique for generating multispecific antibodies directly on the cell surface at the site of action. The method involves a half-antibody exchange reaction between two 2/3-IgGs or two 2/3-BiFabs, which are destabilized in one half by asymmetric perturbing mutations. This fosters the generation of correctly assembled full-length bi- or multispecific antibodies. Notably, the method is performed in the absence of hinge region disulfide bonds in the starting 2/3-IgGs or 2/3-BiFabs.

Career Highlights

Throughout his career, Steffen Dickopf has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise in antibody technology and contribute to significant advancements in the field.

Collaborations

Steffen has collaborated with esteemed colleagues such as Ulrich Brinkmann and Klaus Mayer. These partnerships have facilitated the exchange of ideas and fostered innovation in antibody research.

Conclusion

Steffen Dickopf's work in the generation of multispecific antibodies represents a significant advancement in biochemistry. His innovative methods and collaborations with leading professionals in the field highlight his commitment to improving therapeutic solutions. His contributions are poised to make a lasting impact on the medical community.